Anti-tumour activity of tivozanib, a pan-inhibitor of VEGF receptors, in therapy-resistant ovarian carcinoma cells.
about
Ovarian Cancers: Genetic Abnormalities, Tumor Heterogeneity and Progression, Clonal Evolution and Cancer Stem Cells.Genetic and Epigenetic of Medullary Thyroid Cancer.Current Diagnostic Status of Pheochromocytomaand Future Perspective: A Mini Review.Efficacy and safety of apatinib in advance osteosarcoma with pulmonary metastases: A single-center observational study
P2860
Anti-tumour activity of tivozanib, a pan-inhibitor of VEGF receptors, in therapy-resistant ovarian carcinoma cells.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 06 April 2017
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Anti-tumour activity of tivoza ...... stant ovarian carcinoma cells.
@en
Anti-tumour activity of tivoza ...... stant ovarian carcinoma cells.
@nl
type
label
Anti-tumour activity of tivoza ...... stant ovarian carcinoma cells.
@en
Anti-tumour activity of tivoza ...... stant ovarian carcinoma cells.
@nl
prefLabel
Anti-tumour activity of tivoza ...... stant ovarian carcinoma cells.
@en
Anti-tumour activity of tivoza ...... stant ovarian carcinoma cells.
@nl
P2093
P2860
P50
P356
P1433
P1476
Anti-tumour activity of tivoza ...... stant ovarian carcinoma cells.
@en
P2093
Ardeshir Ghavamzadeh
Ensieh M Poursani
Farima Moghaddaskho
Farinaz Barghi
Ghazaleh Zarrinrad
Haniyeh Eyvani
Hassan Yousefi
Kamran Alimoghaddam
Leila Dardaei
Majid Momeny
P2860
P2888
P356
10.1038/SREP45954
P407
P50
P577
2017-04-06T00:00:00Z